Investors · Key figures and stats · Investor information · About us · Our strategy · Corporate governance · Discover · About the spin-off · Press releases and latest ...
Missing: xlrn | Show results with:xlrn
Investor Relations. Overview · News · Events & Presentations · Events · Presentations ... agilon health Sets Date to Report First Quarter 2024 Financial Results.
Missing: xlrn | Show results with:xlrn
Acceleron Pharma Inc (US:XLRN) has 1 institutional owners and shareholders ... Investor, Type, Avg Price (Est) ... relation to any financial matter you should ...
Acceleron Reports Third Quarter 2021 Financial Results ... (Nasdaq:XLRN) ... Acceleron Pharma Inc. Investors: Jamie Bernard, IRC, 617-301-9650. Associate Director, ...
Investor FAQs · Email Alerts · Contact Us · Investor Relations. News Release Details. Facebook; Twitter · Email · Tumblr · LinkedIn · News & Events · Stock ...
Short-term and long-term investments consist of investment grade corporate obligations, treasury notes, asset backed securities, and certificates of deposit.
Sep 30, 2021 · (Nasdaq: XLRN), a publicly traded biopharmaceutical company, today announced that the companies have entered into a definitive agreement under ...
Acceleron Pharma Inc. Banner Image. Acceleron Pharma Inc. Ticker XLRN. Exchange ... 2019 Annual Report View Annual Report Download. Acceleron Pharma Inc. 2018 ...
The Investor Relations website contains information about ACELYRIN, INC.'s business for stockholders, potential investors, and financial analysts.
Missing: xlrn | Show results with:xlrn
Sep 30, 2021 · INVESTORS AND SECURITY HOLDERS ARE URGED TO READ CAREFULLY BOTH THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO. PURCHASE, A RELATED LETTER OF ...
Missing: xlrn | Show results with:xlrn